Xolegel Approval History
- FDA approved: Yes (First approved July 28th, 2006)
- Brand name: Xolegel
- Generic name: ketoconazole
- Previous name: Sebazole
- Company: Barrier Therapeutics, Inc.
- Treatment for: Seborrheic Dermatitis
Xolegel is a topical waterless gel formulation of the antifungal agent ketoconazole, applied once-daily for the treatment of seborrheic dermatitis in immunocompetent adults and children twelve years of age and older.
Development History and FDA Approval Process for Xolegel
|Jul 28, 2006||Xolegel Gel Barrier Therapeutics, Inc. - Treatment for Seborrheic Dermatitis|
|Dec 9, 2005||Barrier Therapeutics Announces FDA Acceptance of its New Drug Application for Sebazole Topical Gel|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.